Stimulus Properties for Visual Attention
What You Need to Know Before You Apply
What is the purpose of this trial?
The trial aims to explore how the human brain decides what to pay attention to visually. Researchers seek to understand how people focus on important stimuli, like a bright light, while ignoring distractions. Participants will view screens with various shapes and colors to assess how quickly they can identify certain features, even amidst distractions. This research could aid in understanding and treating conditions like schizophrenia and Alzheimer's, which affect visual information processing. Individuals with normal or corrected vision who often need to visually distinguish important objects might be well-suited for this trial. As an unphased trial, this study offers participants the chance to contribute to foundational research that could lead to breakthroughs in understanding visual attention and related conditions.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this protocol is safe for participants?
Research shows that treatments using visual search tasks are generally safe for participants. Studies have found that people handle these tasks well, which involve looking at screens and describing what they see. Reports of harmful side effects do not exist, as these tasks mainly involve noticing and responding to things like colors, shapes, or movement.
These visual tasks help researchers understand how people focus on different things they see. They allow scientists to learn more about how the brain works without causing harm to participants. Overall, this type of research is safe and does not involve physical risks.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores how we process visual information in a way that's different from current methods. Unlike traditional approaches that focus on general visual attention, this trial investigates the specific role of feature dimension maps, like color, motion, and shape, in visual cognition. By probing these unique aspects, the trial aims to uncover new insights into how our brains identify and locate objects in complex visual environments, potentially leading to advanced techniques in improving visual attention and cognitive processing.
What evidence suggests that this trial's treatments could be effective for visual attention?
Research has shown that the brain uses 'priority maps' to decide what to focus on. These maps help by considering how much something stands out (salience) and its importance (relevance). In this trial, participants will complete a visual search task to explore these concepts. Studies have found that during a visual search, attention is influenced by the similarity between the target and surrounding items, known as distractors. Even if a distractor appears different, it can still impact the effectiveness of finding the target. Understanding these interactions helps explain how the brain selects focus, which could aid in diagnosing or treating conditions like schizophrenia or Alzheimer's disease that affect visual attention.26789
Who Is on the Research Team?
Tommy C Sprague
Principal Investigator
University of California, Santa Barbara
Are You a Good Fit for This Trial?
This trial is for individuals interested in how we pay attention to important objects in our environment. Participants should be able to look at displays and report on visual stimuli. There are no specific inclusion or exclusion criteria provided, suggesting it may be open to a wide range of volunteers without particular health conditions.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants complete a visual search task involving unique target items based on specific feature dimensions
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Probing the Role of Feature Dimension Maps in Visual Cognition
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Santa Barbara
Lead Sponsor
National Eye Institute (NEI)
Collaborator